# Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation

> **NCT00003611** · NA · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 129 (actual)

## Conditions studied

- Non-melanomatous Skin Cancer

## Interventions

- **DRUG:** acitretin
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00003611
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2003-02
- **Final completion:** 2003-06
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2016-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003611, "Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00003611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*